🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

8,395 results for “La” Clear

  1. low-dose rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial

  2. low-dose tenecteplase intravenous thrombolysis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke Patients

    approved small molecule active

    1 trial

  3. low-dose ticagrelor

    The First People's Hospital of Lianyungang

    Platelet Reactivity

    approved small molecule completed

    1 trial

  4. melphalan hydrochloride for injection

    CASI Pharmaceuticals

    Multiple Myeloma

    approved small molecule active

    2 trials

  5. methoxy polyethylene glycol-epoetin beta [Mircera]

    Hoffmann-La Roche

    Anemia

    approved small molecule terminated

    2 trials

  6. midazolam

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mechanical Ventilation

    approved small molecule active

    1 trial

  7. minimally invasive cholecystolithotomy with gallbladder reservation

    The First People's Hospital of Lianyungang

    Gallstones

    approved other active

    1 trial

  8. morphine

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    approved small molecule completed

    1 trial

  9. morphine sulfate

    Pacira Ireland Limited

    Bowel Obstruction

    approved small molecule terminated

    1 trial

  10. mycophenolate mofetil

    United Therapeutics Europe Ltd

    IGA Nephropathy

    approved small molecule completed

    1 trial

  11. mycophenolate mofetil (Myfenax)

    Teva Pharma GmbH

    Stable Renal Transplant Recipients

    approved small molecule terminated

    1 trial

  12. naltrexone for extended release injectable suspension

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  13. neoadjuvant therapy

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma Resectable

    approved other active

    1 trial

  14. pegylated interferon alpha and plus ribavirin

    Hospital Authority, Hong Kong

    Chronic Hepatitis C

    approved small molecule completed

    1 trial

  15. pioglitazone

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  16. placebo

    Shandong University

    Sedation

    approved small molecule active

    1 trial

  17. placebo

    Takeda

    Constipation

    approved small molecule completed

    1 trial

  18. primaquine

    Repatha

    Malaria, Vivax

    approved small molecule terminated

    1 trial

  19. profound neuromuscular blockade

    The First People's Hospital of Lianyungang

    Profound Muscle Relaxation

    approved small molecule active

    1 trial

  20. quetiapine fumarate tablet (Seroquel)

    The First People's Hospital of Lianyungang

    Bipolar Disorder

    approved small molecule active

    1 trial

  21. rt-PA

    Takeda

    Lacunar Stroke

    approved small molecule active

    1 trial

  22. sodium oxybate

    Jazz Pharmaceuticals Ireland Limited

    Sleep

    approved small molecule completed

    1 trial

  23. sodium zirconium cyclic silicate

    The First People's Hospital of Lianyungang

    Potassium Imbalance

    approved small molecule active

    1 trial

  24. tasimelteon 20 mg capsule

    Vanda Pharmaceuticals Netherlands B.V.

    Non-24-Hour-Sleep-Wake Disorder

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources